Stage FocusSeries A, Series B+
GeographyUK, Europe
TypeFamily Office
Last Activity2024
Industry Focus
Industries
QuantumBiotechMedtech
Technical BenchLimited
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
Lansdowne Partners was founded in 1998 in London as one of Europe's earliest hedge funds, reaching peak AUM of $21B in 2015. The firm continues to manage assets for major institutional investors, with a venture arm that has made 46 investments focused on Series A and B.
The deep tech investments are genuine — Oxford Ionics (quantum computing), genomics, and nature restoration (including leading a...
Notable Investments
O
Oxford IonicsG
GenomicsN
NattergalSimilar Funds
Amadeus Capital Partners
Cambridge, United Kingdom
Pure DeepTechQuantumAIBiotechSeedSeries A
Bpifrance
Paris, France
GeneralistQuantumAIDefenseSeedSeries A
IQ Capital
Cambridge, United Kingdom
Pure DeepTechQuantumAIRoboticsSeedSeries A
Alumni Ventures Deep Tech Fund
Boston, United States
GeneralistQuantumAISpacePre-SeedSeed
DeepTech & Climate Fonds (DTCF)
Berlin, Germany
Pure DeepTechQuantumClimate TechAISeries ASeries B+
EIC Fund
Brussels, Belgium
Pure DeepTechQuantumBiotechAISeedSeries A